PortViewPortView
Ocata Therapeutics logo

Ocata Therapeutics (OCAT) Stock Analysis

NASDAQHealthcareBiotechnology

$8.47+0.00%
52-week range$8.47
$3.06$8.71

What Ocata Therapeutics does

Ocata Therapeutics Inc. (NASDAQ: OCAT) is a Biotechnology company in the Healthcare sector.

Key metrics

Market cap
$0
P/E (TTM)
-1.29
EPS (TTM)
$-6.58
Beta
0.69
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$8.45
200-day avg
$6.07
52-week high
$8.71
52-week low
$3.06

ETFs linked to OCAT

Broad-market and Healthcare sector ETFs an investor holding Ocata Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how OCAT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze OCAT in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Ocata Therapeutics?
Ocata Therapeutics trades under the ticker OCAT on NASDAQ.
Which exchange is OCAT listed on?
OCAT is listed on NASDAQ.
What sector does Ocata Therapeutics operate in?
Ocata Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze OCAT in a portfolio?
PortView shows OCAT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.